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Abstract 
Aims: Hypermanganesemia is commonly recognized in human patients with hepatic insufficiency and porto-
systemic shunting.  Since manganese is neurotoxic, increases in brain manganese concentrations have been 
implicated in the development of hepatic encephalopathy although a direct causative role has yet to be 
demonstrated. The aim was to evaluate manganese concentrations in dogs with a naturally occurring congenital 
shunt before and after attenuation as well as longitudinally following the changes in hepatic encephalopathy 
grade and extent of portosystemic shunting.  
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Results: Our study demonstrated that attenuation of the shunt resolved encephalopathy, significantly reduced 
portosystemic shunting yet a hypermanganasemic state persisted.  
Conclusion: This study demonstrates that resolution of hepatic encephalopathy can occur without the correction 
of hypermanganesemia, indicating that increased manganese concentrations alone do not play a causative role in 
encephalopathy.  Our study further demonstrates the value of the canine congenital portosystemic shunt as a 
naturally occurring spontaneous model of human hepatic encephalopathy.  
Running title:  Hypermanganesemia after shunt attenuation  
 
Keywords ; canine, shunt, manganese, liver 
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Introduction 
Hepatic encephalopathy (HE) is a common neuropsychiatric syndrome which occurs in patients with liver 
disease.  The pathogenesis of HE is multifactorial with ammonia and inflammation currently considered to be 
the main causes of neurological disturbances in patients with liver disease. However, other metabolic 
disturbances, notably in sodium homeostasis, have been linked to the development of HE (Mas 2006, McPhail 
et al. 2010).  
 
Human patients with liver disease frequently develop hypermanganesemia (Spahr et al. 1996). Dietary 
manganese (Mn) is efficiently absorbed through the gastrointestinal tract, then extracted by hepatocytes 
(Schramm and Brandt 1986). Absorbed Mn is then excreted in bile against a high concentration gradient 
(Klaassen 1974). This process is extremely efficient and only approximately 2% of absorbed Mn ultimately 
reaches the systemic circulation (Davis et al. 1993).  In the situation of reduced hepatic function and 
portosystemic shunting, high concentrations of Mn are delivered into the systemic circulation (Mizoguchi et al. 
2001, Uchino et al. 2007)  . As Mn is neurotoxic, hypermanganesemia has been linked to the development of 
HE (Layrargues et al. 1998).  
 
The pathogenesis of Mn neurotoxicity appears to be multifactorial.  Astrocytes accumulate high Mn 
concentrations, causing release of reactive oxygen species, an increase in peripheral type benzodiazepine 
receptors and also neurosteroid production (Aschner et al. 1992). Manganese has also been shown to potentiate 
microglial release of inflammatory mediators in response to LPS and also increase ammonia concentrations in 
the CNS (Jayakumar et al. 2004, Filipov et al. 2005, Butterworth 2008, Rivera-Mancia et al. 2012).  
 
Despite the established association between liver disease and hypermanganesemia, the precise role of Mn in the 
development of HE remains unclear.  Aside from case reports demonstrating a reduction in globus pallidus 
hyperintensity, a finding which is pathognomic for Mn deposition, after occlusion of porto-systemic shunts and 
treatment for hepatic encephalopathy, there is only one study in humans which measured whole blood 
manganese before and after an improvement in hepatic function (Taguchi et al. 1999, Lazeyras et al. 2002). This 
study examined Mn concentrations before and after orthotopic  liver transplantation (OLT) which failed to 
demonstrate a significant reduction in Mn concentrations 4 months after transplant. Furthermore, Mn 
concentrations remained increased in 6 of 12 patients that had increased pre-operative concentrations. In 
addition, Mn concentrations became increased in a further 3 that had normal concentrations pre-operatively.  
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Potential explanations for this finding include the persistence of portal-systemic collaterals, recurrence of 
hepatitis or concurrent disease contributing to high Mn concentrations. However, interpretation of this data is 
difficult due to the presence of a wide range of comorbidities in the patient cohort. Consequently, there is a clear 
need to clarify whether the reducing portosystemic shunting reduces Mn concentrations.  
 
One of the most common congenital abnormalities in dogs is a portosystemic shunt (cPSS) which commonly 
causes spontaneous HE. We have demonstrated that the pathophysiology of HE in dogs with liver disease is 
very similar to human HE, with ammonia and inflammation playing a key role in the development of 
neurological abnormalities in dogs with a cPSS (Shawcross et al. 2004, Shawcross et al. 2007, Gow et al. 2012, 
Tivers et al. 2014).   Crucially, we have also demonstrated that dogs with a cPSS frequently have an increase in 
Mn concentrations (Gow et al. 2010).   Consequently, dogs with a cPSS are a highly informative, spontaneous 
model of human HE in which the pathogenesis of neurological complications associated with liver disorders can 
be explored without the need for the inducing liver disease in otherwise healthy animals.  
 
In dogs with a cPSS, portosystemic shunting can be surgically attenuated with subsequent resolution of HE in 
the majority of cases (Hunt and Hughes 1999). This offers an excellent natural experimental system, free from 
many of the confounding variables which are invariably present in human studies, in which to examine whether 
the manganese concentrations normalise following surgical attenuation of a portosystemic shunt (Lazeyras et al. 
2002).   As hepatic blood  flow improves after  surgery, and hepatic volume increases rapidly, it would be 
expected that  this would allow efficient hepatic first pass extraction of portal blood Mn and systemic 
concentrations would reduce after shunt ligation (Kummeling et al. 2010).  The objective of this study was to 
test the hypothesis that cPSS attenuation would resolve HE, portosystemic shunting and hypermanganesemia in 
dogs with a cPSS. 
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Methods 
Dogs with a diagnosis of a cPSS (shunt confirmed by direct visualisation, ultrasonography and/or porto-
venography) were enrolled into the study. Whole blood EDTA samples were collected before and after shunt 
attenuation.  A bile acid stimulation test, which is a well established and widely used assay to assess for the 
presence of portosystemic shunting in dogs, was also performed (Center et al. 1991).   At time of sampling, the 
grade of HE was recorded based on a previously described system (Rothuizen 2009). The whole blood EDTA 
samples were frozen at -70oC before being transported on dry ice as a batch to the Scottish Trace Element and 
Micronutrient Reference Laboratory. Manganese concentrations were determined in whole blood by graphite 
furnace atomic absorption spectrometry after dilution with Triton X-100 solution.  The interassay coefficient of 
variation was 5.4%.  Bile acid measurement was performed on an ILab 650 using a colorimetric, 2 point kinetic 
fixed time enzymatic reaction by Dialab. 
A Wilcoxon matched-pairs test was used to compare HE scores, whole blood Mn and bile acids before and after 
surgical ligation. Statistical analysis was performed with GraphPad Prism version 5.00 for Windows (GraphPad 
Software, San Diego California USA) and P of <0.05 was considered significant. The study was approved by 
the University of Edinburgh Veterinary Ethics Committee.   
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Results 
Whole blood Mn concentrations were measured before and after surgery in 26 dogs with a cPSS  (2 males 
neutered, 7 intact males, 14 intact females, 3 females neutered, age range 17 weeks to 5 years 11 months, mean 
21 months). All dogs were diagnosed with an extra-hepatic shunting vessel. The median time between sampling 
was 4 weeks. 
 
Post-prandial bile acid concentrations were significantly lower post-operatively than prior to surgery (median 
pre-surgery 218µmol/L, media post-surgery 39 µmol/L , p=0.0006). Twelve dogs had signs of hepatic 
encephalopathy and 14 were asymptomatic prior to surgery.   No dog exhibited signs of HE at the time of post 
attenuation sampling. Hepatic encephalopathy scores were significantly lower at the time of post-operative 
sampling compared to the pre-operative time point (p=0.0012).  There was no significant difference between the 
pre and post-surgery whole blood Mn measurements (figure 1, median pre-surgery 2969nmol/L, media post-
surgery 2296 nmol/L , p=0.12). Manganese concentrations increased in 8 dogs after shunt attenuation.   
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Discussion 
The central finding of this study was that clinical signs of HE resolved and portosystemic shunting significantly 
decreased following shunt attenuation yet, whole blood manganese concentrations did not decrease 
significantly. Indeed, in eight individuals Mn concentrations increased.  This finding is consistent with the OLT 
study where Mn concentrations remained increased after liver transplantation (Lazeyras et al. 2002).  
 
The reason(s) why Mn concentrations remain high in dogs post cPSS attenuation is unclear. Dogs with a cPSS 
have reduced hepatic volume and post-operatively, despite improved portal delivery of Mn to the liver, a lack of 
functional hepatocytes may initially prevent efficient extraction of Mn (Stieger et al. 2007). Hepatic volume has 
been shown to increase rapidly post-operatively with the greatest increase between days 0 to 8 post attenuation, 
thus it would be expected that efficiency of portal Mn extraction would likewise increase (Kummeling et al. 
2010).   As Mn distribution is reasonably uniform through most body tissues, cPSS cases would have tissue Mn 
to equilibrate with whole blood concentrations, also slowing post-operative resolution of hypermanganesaemia 
(Dobson et al. 2004).  It has also been demonstrated that systemic Mn is less efficiently extracted by the liver 
than portally delivered Mn (Teeguarden et al. 2007).  This may be due to difference in oxidation state; the 
majority of portally delivered Manganese is Mn2+ however during systemic circulation this can be oxidised by 
ceruloplasmin to Mn3+ and bound to transferrin (Teeguarden et al. 2007)  .    
 
Longer-term monitoring of whole blood Mn in cases of cPSS which have undergone surgical attenuation would 
be useful to assess if concentrations gradually decrease. Persistent hypermanganesemia after clinically 
successful surgery may have significant clinical consequences with continued CNS Mn deposition causing 
subtle long term neurological abnormalities that current canine HE scoring systems cannot detect.  Long term 
follow up of neurological status and ultimately examination of CNS Mn concentration and histopathological 
examination would be insightful.  
 
In summary, this study demonstrated that dogs with a congenital porto-systemic shunt are an instructive natural 
model in which Mn homeostasis can be probed, free from many of the confounding factors present in humans 
undergoing OLT and without the need to induce disease in otherwise healthy animals.  Despite clinical 
resolution of HE and a significant reduction in portosystemic shunting, hypermanganesemia remained present in 
these dogs. 
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Figure 1: Whole blood manganese concentrations of 26 dogs with a congenital portosystemic shunt  before 
(Pre), and after (Post) surgical shunt ligation.  There was no significant difference in concentrations before and 
after ligation (p=0.12). 
 
 
